Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

AEOL-10150 doubles survival in primate model of radiation-induced lung injury

May 5, 2015

Adapt Pharma successfully completes pharmacokinetic study of intranasal naloxone

April 24, 2015

FDA approves filgrastim for myelosuppression in acute radiation injury

April 23, 2015

Tamoxifen found to inhibit the effects of amphetamine

April 21, 2015

Northeastern University patents CB1 receptor modulators

March 12, 2015

Substance abuse candidate GS-6637 well tolerated in healthy volunteers

March 10, 2015

Reversible change in enzyme's substrate specificity accelerates elimination of toxic acetaldehyde

Feb. 27, 2015

Cerecor acquires kappa opioid receptor antagonist from Eli Lilly

Feb. 23, 2015

Pluristem Therapeutics reports results for PLX-R18 in animal model of ARS

Feb. 18, 2015

Elite Pharmaceuticals plans phase III trial of abuse-deterrent opioid

Feb. 18, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...